Assignee
LANDOS BIOPHARMA INC
US·19 granted patents·5 pending applications·83 citations·filing 2016–2023
Top patents by PatentIndex Score
24 records- 0196US10849895B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2020·Granted Dec 1, 2020·4 cites·40 claims
- 0295US10493072B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2018·Granted Dec 3, 2019·14 cites·27 claims
- 0395US10201538B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2018·Granted Feb 12, 2019·12 cites·16 claims
- 0495US10028950B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2017·Granted Jul 24, 2018·15 cites·18 claims
- 0595US9839635B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·16 cites·22 claims
- 0694US11117881B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2020·Granted Sep 14, 2021·2 cites·38 claims
- 0793US10682349B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2019·Granted Jun 16, 2020·8 cites·36 claims
- 0891US10487057B1NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Nov 26, 2019·5 cites·1 claims
- 0989US11180473B2PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Nov 23, 2021·2 cites·55 claims
- 1087US11197891B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithLANDOS BIOPHARMA INC·Filed 2018·Granted Dec 14, 2021·2 cites·23 claims
- 1187US10676436B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Jun 9, 2020·2 cites·38 claims
- 1285US11548885B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jan 10, 2023·1 cites·29 claims
- 1381US2024166601A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1478US11571419B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2020·Granted Feb 7, 2023·0 cites·13 claims
- 1575US11680045B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·21 claims
- 1675US11377437B2Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·0 cites·30 claims
- 1772US11492342B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)LANDOS BIOPHARMA INC·Filed 2021·Granted Nov 8, 2022·0 cites·15 claims
- 1872US2023192652A1Plxdc2 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1970US11066364B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2020·Granted Jul 20, 2021·0 cites·30 claims
- 2069US11597717B2Substituted imidazoles as PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Mar 7, 2023·0 cites·31 claims
- 2166US11459310B2LANCL ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Oct 4, 2022·0 cites·30 claims
- 2266US2023128450A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2359US2024270743A1Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereofLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2457US2022152019A1Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of surface tissuesLANDOS BIOPHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LANDOS BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →